RanBPM: a potential therapeutic target for modulating diverse physiological disorders
• The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases.
Gespeichert in:
| Autor*in: |
Das, Soumyadip [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Triazolopyridazine LRRK2 kinase inhibitors - 2013, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:22 ; year:2017 ; number:12 ; pages:1816-1824 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.drudis.2017.08.005 |
|---|
| Katalog-ID: |
ELV041195477 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV041195477 | ||
| 003 | DE-627 | ||
| 005 | 20230624083205.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180725s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drudis.2017.08.005 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000045A.pica |
| 035 | |a (DE-627)ELV041195477 | ||
| 035 | |a (ELSEVIER)S1359-6446(17)30075-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 630 |q VZ |
| 084 | |a 22 |2 ssgn | ||
| 084 | |a 46.00 |2 bkl | ||
| 100 | 1 | |a Das, Soumyadip |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| 264 | 1 | |c 2017 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. | ||
| 700 | 1 | |a Suresh, Bharathi |4 oth | |
| 700 | 1 | |a Kim, Hyongbum Henry |4 oth | |
| 700 | 1 | |a Ramakrishna, Suresh |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Triazolopyridazine LRRK2 kinase inhibitors |d 2013 |g Amsterdam [u.a.] |w (DE-627)ELV011759550 |
| 773 | 1 | 8 | |g volume:22 |g year:2017 |g number:12 |g pages:1816-1824 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.drudis.2017.08.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 46.00 |j Tiermedizin: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 22 |j 2017 |e 12 |h 1816-1824 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
s d sd |
|---|---|
| matchkey_str |
dassoumyadipsureshbharathikimhyongbumhen:2017----:abmptnilhrpuitrefrouaigiesp |
| hierarchy_sort_str |
2017 |
| bklnumber |
46.00 |
| publishDate |
2017 |
| allfields |
10.1016/j.drudis.2017.08.005 doi GBV00000000000045A.pica (DE-627)ELV041195477 (ELSEVIER)S1359-6446(17)30075-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Das, Soumyadip verfasserin aut RanBPM: a potential therapeutic target for modulating diverse physiological disorders 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. Suresh, Bharathi oth Kim, Hyongbum Henry oth Ramakrishna, Suresh oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:22 year:2017 number:12 pages:1816-1824 extent:9 https://doi.org/10.1016/j.drudis.2017.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 22 2017 12 1816-1824 9 045F 610 |
| spelling |
10.1016/j.drudis.2017.08.005 doi GBV00000000000045A.pica (DE-627)ELV041195477 (ELSEVIER)S1359-6446(17)30075-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Das, Soumyadip verfasserin aut RanBPM: a potential therapeutic target for modulating diverse physiological disorders 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. Suresh, Bharathi oth Kim, Hyongbum Henry oth Ramakrishna, Suresh oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:22 year:2017 number:12 pages:1816-1824 extent:9 https://doi.org/10.1016/j.drudis.2017.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 22 2017 12 1816-1824 9 045F 610 |
| allfields_unstemmed |
10.1016/j.drudis.2017.08.005 doi GBV00000000000045A.pica (DE-627)ELV041195477 (ELSEVIER)S1359-6446(17)30075-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Das, Soumyadip verfasserin aut RanBPM: a potential therapeutic target for modulating diverse physiological disorders 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. Suresh, Bharathi oth Kim, Hyongbum Henry oth Ramakrishna, Suresh oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:22 year:2017 number:12 pages:1816-1824 extent:9 https://doi.org/10.1016/j.drudis.2017.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 22 2017 12 1816-1824 9 045F 610 |
| allfieldsGer |
10.1016/j.drudis.2017.08.005 doi GBV00000000000045A.pica (DE-627)ELV041195477 (ELSEVIER)S1359-6446(17)30075-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Das, Soumyadip verfasserin aut RanBPM: a potential therapeutic target for modulating diverse physiological disorders 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. Suresh, Bharathi oth Kim, Hyongbum Henry oth Ramakrishna, Suresh oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:22 year:2017 number:12 pages:1816-1824 extent:9 https://doi.org/10.1016/j.drudis.2017.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 22 2017 12 1816-1824 9 045F 610 |
| allfieldsSound |
10.1016/j.drudis.2017.08.005 doi GBV00000000000045A.pica (DE-627)ELV041195477 (ELSEVIER)S1359-6446(17)30075-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl Das, Soumyadip verfasserin aut RanBPM: a potential therapeutic target for modulating diverse physiological disorders 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. Suresh, Bharathi oth Kim, Hyongbum Henry oth Ramakrishna, Suresh oth Enthalten in Elsevier Science Triazolopyridazine LRRK2 kinase inhibitors 2013 Amsterdam [u.a.] (DE-627)ELV011759550 volume:22 year:2017 number:12 pages:1816-1824 extent:9 https://doi.org/10.1016/j.drudis.2017.08.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 46.00 Tiermedizin: Allgemeines VZ AR 22 2017 12 1816-1824 9 045F 610 |
| language |
English |
| source |
Enthalten in Triazolopyridazine LRRK2 kinase inhibitors Amsterdam [u.a.] volume:22 year:2017 number:12 pages:1816-1824 extent:9 |
| sourceStr |
Enthalten in Triazolopyridazine LRRK2 kinase inhibitors Amsterdam [u.a.] volume:22 year:2017 number:12 pages:1816-1824 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Tiermedizin: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Triazolopyridazine LRRK2 kinase inhibitors |
| authorswithroles_txt_mv |
Das, Soumyadip @@aut@@ Suresh, Bharathi @@oth@@ Kim, Hyongbum Henry @@oth@@ Ramakrishna, Suresh @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011759550 |
| dewey-sort |
3610 |
| id |
ELV041195477 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041195477</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624083205.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drudis.2017.08.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000045A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041195477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1359-6446(17)30075-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">22</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">46.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Das, Soumyadip</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">RanBPM: a potential therapeutic target for modulating diverse physiological disorders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suresh, Bharathi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Hyongbum Henry</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramakrishna, Suresh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Triazolopyridazine LRRK2 kinase inhibitors</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011759550</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1816-1824</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drudis.2017.08.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">46.00</subfield><subfield code="j">Tiermedizin: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2017</subfield><subfield code="e">12</subfield><subfield code="h">1816-1824</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Das, Soumyadip |
| spellingShingle |
Das, Soumyadip ddc 610 ddc 540 ddc 630 ssgn 22 bkl 46.00 RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| authorStr |
Das, Soumyadip |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011759550 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences 630 - Agriculture & related technologies |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| topic |
ddc 610 ddc 540 ddc 630 ssgn 22 bkl 46.00 |
| topic_unstemmed |
ddc 610 ddc 540 ddc 630 ssgn 22 bkl 46.00 |
| topic_browse |
ddc 610 ddc 540 ddc 630 ssgn 22 bkl 46.00 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b s bs h h k hh hhk s r sr |
| hierarchy_parent_title |
Triazolopyridazine LRRK2 kinase inhibitors |
| hierarchy_parent_id |
ELV011759550 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry 630 - Agriculture |
| hierarchy_top_title |
Triazolopyridazine LRRK2 kinase inhibitors |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011759550 |
| title |
RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| ctrlnum |
(DE-627)ELV041195477 (ELSEVIER)S1359-6446(17)30075-2 |
| title_full |
RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| author_sort |
Das, Soumyadip |
| journal |
Triazolopyridazine LRRK2 kinase inhibitors |
| journalStr |
Triazolopyridazine LRRK2 kinase inhibitors |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
1816 |
| author_browse |
Das, Soumyadip |
| container_volume |
22 |
| physical |
9 |
| class |
610 610 DE-600 540 VZ 610 VZ 630 VZ 22 ssgn 46.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Das, Soumyadip |
| doi_str_mv |
10.1016/j.drudis.2017.08.005 |
| dewey-full |
610 540 630 |
| title_sort |
ranbpm: a potential therapeutic target for modulating diverse physiological disorders |
| title_auth |
RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| abstract |
• The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. |
| abstractGer |
• The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. |
| abstract_unstemmed |
• The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
12 |
| title_short |
RanBPM: a potential therapeutic target for modulating diverse physiological disorders |
| url |
https://doi.org/10.1016/j.drudis.2017.08.005 |
| remote_bool |
true |
| author2 |
Suresh, Bharathi Kim, Hyongbum Henry Ramakrishna, Suresh |
| author2Str |
Suresh, Bharathi Kim, Hyongbum Henry Ramakrishna, Suresh |
| ppnlink |
ELV011759550 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.drudis.2017.08.005 |
| up_date |
2024-07-06T19:28:38.711Z |
| _version_ |
1803859125821505536 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041195477</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624083205.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drudis.2017.08.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000045A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041195477</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1359-6446(17)30075-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">22</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">46.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Das, Soumyadip</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">RanBPM: a potential therapeutic target for modulating diverse physiological disorders</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The diverse biological functions of RanBPM and its interacting partners are reviewed. • RanBPM is linked to various proteins and cellular pathways leading to modulation of numerous physiological disorders. • RanBPM can be a potential therapeutic target for dreadful diseases.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suresh, Bharathi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kim, Hyongbum Henry</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramakrishna, Suresh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Triazolopyridazine LRRK2 kinase inhibitors</subfield><subfield code="d">2013</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011759550</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:22</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1816-1824</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drudis.2017.08.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">46.00</subfield><subfield code="j">Tiermedizin: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">22</subfield><subfield code="j">2017</subfield><subfield code="e">12</subfield><subfield code="h">1816-1824</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.398529 |